Venture capital firm

Advent France Biotechnology

French life sciences venture capital firm investing in early-stage European healthcare start-ups

Write a review

Industrial
Medical
Early Stage
Partners
+5 more

Visit Website Get introducedRequest an introduction Write a Review

Own this listing? Claim it

TrustList summary

Advent France Biotechnology, which operates as AdBio Partners, is a French venture capital firm. It focuses on early-stage life sciences start-ups across Europe and helps to build them from scientific discoveries.

What Advent France Biotechnology offers

Early-stage investment: backs young life sciences companies.
Company creation: works with scientific founders and academic institutions to start and grow ventures.
Discovery sourcing: looks for medical discoveries across several therapeutic areas.
Syndicate access: brings in international venture syndicates and a network of scientific and industrial partners.

Clients

Research institutions, technology transfer offices and scientific founders in Europe. The team calls itself both entrepreneurs and investors, with backgrounds in business, science and finance.

Key facts

Based in: France
Sector: life sciences and healthcare
Stage: early-stage

Summary written by TrustList from the business's own published information, Oct 2026.

Gallery

2 images - click to enlarge

Rankings

Advent France Biotechnology is ranked on 4 TrustList rankings: #4 on 1, #11 on 1, #19 on 1 and #26 on 1.

Every ranking orders its listings by their reviews, how complete the profile is and the Trust Score. Advent France Biotechnology has no reviews yet and 3 of the 10 profile details we look for. Where no listing on a page has been reviewed, the order follows the profiles alone.

Venture capital firm · 4 rankings

#4of 19
Montreal
It is the only one of the 19 here listing medical and one of 2 here listing industrial.
Of the 19 here, 5 also cover series and 4 also cover growth stage; 11 also work in Toronto and 6 also work in New York City.
Behind BKR Capital, ahead of BofA Securities.
#11of 13
Barcelona
It is the only one of the 13 here listing early stage and partners.
Of the 13 here, 3 also cover pre seed and 2 also cover seed stage; 5 also work in Madrid and 3 also work in Paris.
Behind Extension Fund, ahead of The Valley Venture Capital.
#19of 79
Biotech investors
It is one of 10 here listing series.
Of the top 65 here, 22 also cover healthtech and 17 also cover science; 14 also work in Boston and 13 also work in San Francisco.
Behind Aditum Bio, ahead of AgFunder.
#26of 83
Paris
It is one of 3 here listing biotech.
Of the top 65 here, 13 also cover partners and 7 also cover private equity; 21 also work in London and 10 also work in Munich.
Behind A Plus Finance, ahead of ArtAssure Ltd..